This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Brain Cancer  • History of Medicine  • Alert me on articles by topic

Lara J. Kunschner, MD

Arch Neurol. 2002;59:642-645.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

History is in essence the telling of a story. The story of our current understanding of medulloblastoma, or cerebellar primitive neuroectodermal tumor, as it is now known, begins with the formidable and exhaustive work of Harvey Cushing, MD (1869-1939). The first recorded foray into the treatment of brain tumors in the United States began in 1888 with the resection of a meningioma by William W. Keen. Surgery at the time was greatly hampered by several conditions that limited the physician encountering a patient suspected of harboring a brain tumor. Little if any progress beyond that of pre-Columbian trepanation was made with regards to neurosurgery until the entry of Cushing into the surgical theaters of The Johns Hopkins Hospital in Baltimore, Md, and later Peter Bent Brigham Hospital in Boston, Mass. As Matson and German¹ wrote in his biography: "Cushing lived at a time when medicine and . . . [Full Text of this Article]

CLASSIFICATION OF BRAIN TUMORS

MEDULLOBLASTOMA AS A DISTINCT ENTITY

CLINICAL FEATURES

SURGICAL TREATMENT

RADIOTHERAPY

From the Department of Neurology, Allegheny General Hospital, Pittsburgh, Pa.